Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study

Background: There is sufficient evidence of the high prevalence of obesity in schizophrenia (SZ) compared to the general population. Previous studies have reported that weight gain correlated with the response to antipsychotics in patients with SZ. Nonetheless, the relationship between body mass ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaofang, Fan, Yong, Ren, Wenchao, Sun, Maodi, Guan, Xiaoni, Xiu, Meihong, Li, Shuyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670888/
https://www.ncbi.nlm.nih.gov/pubmed/38026922
http://dx.doi.org/10.3389/fphar.2023.1264591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670888/
https://www.ncbi.nlm.nih.gov/pubmed/38026922
http://dx.doi.org/10.3389/fphar.2023.1264591

Ejemplares similares